Inflammation-associated microRNA changes in circulating exosomes of heart failure patients

Faheemullah Beg, Ruizhong Wang, Zeb Saeed, Srikant Devaraj, Masoor Kamalesh, Harikrishna Nakshatri

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Objective: MiR-486 and miR-146a are cardiomyocyte-enriched microRNAs that control cell survival and self-regulation of inflammation. These microRNAs are released into circulation and are detected in plasma or in circulating exosomes. Little is known whether heart failure affects their release into circulation, which this study investigated. Results: Total and exosome-specific microRNAs in plasma of 40 heart failure patients and 20 controls were prepared using the miRVana Kit. We measured exosomal and total plasma microRNAs separately because exosomes serve as cargos that transfer biological materials and alter signaling in distant organs, whereas microRNAs in plasma indicate the level of tissue damage and are mostly derived from dead cells. qRT-PCR was used to quantify miR-486, miR-146a, and miR-16. Heart failure did not significantly affect plasma miR-486/miR-16 and miR-146a/miR-16 ratio, although miR-146a/miR-16 showed a trend of elevated expression (2.3 ± 0.79, p = 0.27). By contrast, circulating exosomal miR-146a/miR-16 ratio was higher in heart failure patients (2.46 ± 0.51, p = 0.05). miR-146a is induced in response to inflammation as a part of inflammation attenuation circuitry. Indeed, Tnfα and Gm-csf increased miR-146a but not miR-486 in the cardiomyocyte cell line H9C2. These results, if confirmed in a larger study, may help to develop circulating exosomal miR-146a as a biomarker of heart failure.

Original languageEnglish (US)
Article number751
JournalBMC Research Notes
Volume10
Issue number1
DOIs
StatePublished - Dec 19 2017

Fingerprint

Exosomes
MicroRNAs
Heart Failure
Inflammation
Plasmas
Cardiac Myocytes
Cells
Biomarkers
Biological materials
Cell Survival
Tissue
Cell Line
Polymerase Chain Reaction

Keywords

  • Biomarkers
  • Exosomes
  • Heart failure
  • MicroRNA

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Inflammation-associated microRNA changes in circulating exosomes of heart failure patients. / Beg, Faheemullah; Wang, Ruizhong; Saeed, Zeb; Devaraj, Srikant; Kamalesh, Masoor; Nakshatri, Harikrishna.

In: BMC Research Notes, Vol. 10, No. 1, 751, 19.12.2017.

Research output: Contribution to journalArticle

@article{7781e900f4fe4ed5a29308c375e27f68,
title = "Inflammation-associated microRNA changes in circulating exosomes of heart failure patients",
abstract = "Objective: MiR-486 and miR-146a are cardiomyocyte-enriched microRNAs that control cell survival and self-regulation of inflammation. These microRNAs are released into circulation and are detected in plasma or in circulating exosomes. Little is known whether heart failure affects their release into circulation, which this study investigated. Results: Total and exosome-specific microRNAs in plasma of 40 heart failure patients and 20 controls were prepared using the miRVana Kit. We measured exosomal and total plasma microRNAs separately because exosomes serve as cargos that transfer biological materials and alter signaling in distant organs, whereas microRNAs in plasma indicate the level of tissue damage and are mostly derived from dead cells. qRT-PCR was used to quantify miR-486, miR-146a, and miR-16. Heart failure did not significantly affect plasma miR-486/miR-16 and miR-146a/miR-16 ratio, although miR-146a/miR-16 showed a trend of elevated expression (2.3 ± 0.79, p = 0.27). By contrast, circulating exosomal miR-146a/miR-16 ratio was higher in heart failure patients (2.46 ± 0.51, p = 0.05). miR-146a is induced in response to inflammation as a part of inflammation attenuation circuitry. Indeed, Tnfα and Gm-csf increased miR-146a but not miR-486 in the cardiomyocyte cell line H9C2. These results, if confirmed in a larger study, may help to develop circulating exosomal miR-146a as a biomarker of heart failure.",
keywords = "Biomarkers, Exosomes, Heart failure, MicroRNA",
author = "Faheemullah Beg and Ruizhong Wang and Zeb Saeed and Srikant Devaraj and Masoor Kamalesh and Harikrishna Nakshatri",
year = "2017",
month = "12",
day = "19",
doi = "10.1186/s13104-017-3090-y",
language = "English (US)",
volume = "10",
journal = "BMC Research Notes",
issn = "1756-0500",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Inflammation-associated microRNA changes in circulating exosomes of heart failure patients

AU - Beg, Faheemullah

AU - Wang, Ruizhong

AU - Saeed, Zeb

AU - Devaraj, Srikant

AU - Kamalesh, Masoor

AU - Nakshatri, Harikrishna

PY - 2017/12/19

Y1 - 2017/12/19

N2 - Objective: MiR-486 and miR-146a are cardiomyocyte-enriched microRNAs that control cell survival and self-regulation of inflammation. These microRNAs are released into circulation and are detected in plasma or in circulating exosomes. Little is known whether heart failure affects their release into circulation, which this study investigated. Results: Total and exosome-specific microRNAs in plasma of 40 heart failure patients and 20 controls were prepared using the miRVana Kit. We measured exosomal and total plasma microRNAs separately because exosomes serve as cargos that transfer biological materials and alter signaling in distant organs, whereas microRNAs in plasma indicate the level of tissue damage and are mostly derived from dead cells. qRT-PCR was used to quantify miR-486, miR-146a, and miR-16. Heart failure did not significantly affect plasma miR-486/miR-16 and miR-146a/miR-16 ratio, although miR-146a/miR-16 showed a trend of elevated expression (2.3 ± 0.79, p = 0.27). By contrast, circulating exosomal miR-146a/miR-16 ratio was higher in heart failure patients (2.46 ± 0.51, p = 0.05). miR-146a is induced in response to inflammation as a part of inflammation attenuation circuitry. Indeed, Tnfα and Gm-csf increased miR-146a but not miR-486 in the cardiomyocyte cell line H9C2. These results, if confirmed in a larger study, may help to develop circulating exosomal miR-146a as a biomarker of heart failure.

AB - Objective: MiR-486 and miR-146a are cardiomyocyte-enriched microRNAs that control cell survival and self-regulation of inflammation. These microRNAs are released into circulation and are detected in plasma or in circulating exosomes. Little is known whether heart failure affects their release into circulation, which this study investigated. Results: Total and exosome-specific microRNAs in plasma of 40 heart failure patients and 20 controls were prepared using the miRVana Kit. We measured exosomal and total plasma microRNAs separately because exosomes serve as cargos that transfer biological materials and alter signaling in distant organs, whereas microRNAs in plasma indicate the level of tissue damage and are mostly derived from dead cells. qRT-PCR was used to quantify miR-486, miR-146a, and miR-16. Heart failure did not significantly affect plasma miR-486/miR-16 and miR-146a/miR-16 ratio, although miR-146a/miR-16 showed a trend of elevated expression (2.3 ± 0.79, p = 0.27). By contrast, circulating exosomal miR-146a/miR-16 ratio was higher in heart failure patients (2.46 ± 0.51, p = 0.05). miR-146a is induced in response to inflammation as a part of inflammation attenuation circuitry. Indeed, Tnfα and Gm-csf increased miR-146a but not miR-486 in the cardiomyocyte cell line H9C2. These results, if confirmed in a larger study, may help to develop circulating exosomal miR-146a as a biomarker of heart failure.

KW - Biomarkers

KW - Exosomes

KW - Heart failure

KW - MicroRNA

UR - http://www.scopus.com/inward/record.url?scp=85042329262&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85042329262&partnerID=8YFLogxK

U2 - 10.1186/s13104-017-3090-y

DO - 10.1186/s13104-017-3090-y

M3 - Article

C2 - 29258606

AN - SCOPUS:85042329262

VL - 10

JO - BMC Research Notes

JF - BMC Research Notes

SN - 1756-0500

IS - 1

M1 - 751

ER -